Company registration number SC368552 (Scotland)
MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
BALANCE SHEET
AS AT
30 MARCH 2025
30 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
183,037
219,350
Tangible assets
4
52,648
59,114
235,685
278,464
Current assets
Stocks
50,614
65,012
Debtors
5
119,449
57,997
Cash at bank and in hand
253,397
297,777
423,460
420,786
Creditors: amounts falling due within one year
6
(260,221)
(283,513)
Net current assets
163,239
137,273
Total assets less current liabilities
398,924
415,737
Provisions for liabilities
(4,399)
(5,111)
Net assets
394,525
410,626
Capital and reserves
Called up share capital
20,000
20,000
Profit and loss reserves
374,525
390,626
Total equity
394,525
410,626

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
BALANCE SHEET (CONTINUED)
AS AT
30 MARCH 2025
30 March 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 17 November 2025 and are signed on its behalf by:
Leanne Carey
Director
Company Registration No. SC368552
MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2025
- 3 -
1
Accounting policies
Company information

MBM Shelfco (57) Limited is a private company limited by shares incorporated in Scotland. The registered office is 195 Whitehouse Road, Barnton, Edinburgh, United Kingdom, EH4 6BU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The directors have considered a period of at least twelve months from the date on which these financial statements have been signed and having considered all information available to them, believe it appropriate to prepare the financial statements on a going concern basis. The directors are satisfied that it has adequate resources to continue to operate for the foreseeable future.

1.3
Turnover

Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

1.4
Intangible fixed assets - goodwill

Acquired goodwill is written off in equal instalments over its estimated useful economic life of 20 years.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
10-25% reducing balance
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 MARCH 2025
1
Accounting policies
(Continued)
- 4 -

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

1.15
Government grants

Government grants are recognised at the fair value of the asset receive d or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
21
18
MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 MARCH 2025
- 6 -
3
Intangible fixed assets
Goodwill
£
Cost
At 31 March 2024 and 30 March 2025
726,267
Amortisation and impairment
At 31 March 2024
506,917
Amortisation charged for the year
36,313
At 30 March 2025
543,230
Carrying amount
At 30 March 2025
183,037
At 30 March 2024
219,350
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 31 March 2024
144,526
Additions
44
At 30 March 2025
144,570
Depreciation and impairment
At 31 March 2024
85,412
Depreciation charged in the year
6,510
At 30 March 2025
91,922
Carrying amount
At 30 March 2025
52,648
At 30 March 2024
59,114
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
102,822
36,804
Other debtors
16,627
21,193
119,449
57,997
MBM SHELFCO (57) LIMITED
T/A BARNTON PHARMACY
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 MARCH 2025
- 7 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
146,198
155,204
Corporation tax
9,538
14,552
Other taxation and social security
6,831
6,062
Other creditors
97,654
107,695
260,221
283,513
7
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
130,000
22,430
2025-03-30 2024-03-31 false false false 17 November 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Leanne Carey Sally Arnison Catherine Carey SC368552 2024-03-31 2025-03-30 SC368552 2025-03-30 SC368552 2024-03-30 SC368552 core:NetGoodwill 2025-03-30 SC368552 core:NetGoodwill 2024-03-30 SC368552 core:OtherPropertyPlantEquipment 2025-03-30 SC368552 core:OtherPropertyPlantEquipment 2024-03-30 SC368552 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-30 SC368552 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-30 SC368552 core:CurrentFinancialInstruments 2025-03-30 SC368552 core:CurrentFinancialInstruments 2024-03-30 SC368552 core:ShareCapital 2025-03-30 SC368552 core:ShareCapital 2024-03-30 SC368552 core:RetainedEarningsAccumulatedLosses 2025-03-30 SC368552 core:RetainedEarningsAccumulatedLosses 2024-03-30 SC368552 bus:Director1 2024-03-31 2025-03-30 SC368552 core:Goodwill 2024-03-31 2025-03-30 SC368552 core:FurnitureFittings 2024-03-31 2025-03-30 SC368552 core:MotorVehicles 2024-03-31 2025-03-30 SC368552 2023-03-31 2024-03-30 SC368552 core:NetGoodwill 2024-03-30 SC368552 core:NetGoodwill 2024-03-31 2025-03-30 SC368552 core:OtherPropertyPlantEquipment 2024-03-30 SC368552 core:OtherPropertyPlantEquipment 2024-03-31 2025-03-30 SC368552 bus:PrivateLimitedCompanyLtd 2024-03-31 2025-03-30 SC368552 bus:SmallCompaniesRegimeForAccounts 2024-03-31 2025-03-30 SC368552 bus:FRS102 2024-03-31 2025-03-30 SC368552 bus:AuditExemptWithAccountantsReport 2024-03-31 2025-03-30 SC368552 bus:Director2 2024-03-31 2025-03-30 SC368552 bus:CompanySecretary1 2024-03-31 2025-03-30 SC368552 bus:FullAccounts 2024-03-31 2025-03-30 xbrli:pure xbrli:shares iso4217:GBP